Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)

BACKGROUND: The use of molecular categorisation is shifting paradigm towards the use of molecular information to refine risk stratification in endometrial cancer (EC). To date, evidence to support molecular-guided therapies is limited to retrospective studies and secondary molecular analyses of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Zhu, Changkun, Xie, Hongyu, Chen, Yaxia, Lv, Weiguo, Xie, Xing, Wang, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995864/
https://www.ncbi.nlm.nih.gov/pubmed/36659832
http://dx.doi.org/10.3802/jgo.2023.34.e37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995864/
https://www.ncbi.nlm.nih.gov/pubmed/36659832
http://dx.doi.org/10.3802/jgo.2023.34.e37

Ejemplares similares